Biotech · Public company · Rockville, MD, US

Theriva Biologics, Inc.

Ticker TOVX · SEC CIK 0000894158

Track this companyFree. Adds Theriva Biologics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials41 recruiting or active

Pipeline programs2From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline2

SYN-020 delayed release capsulePhase 1 · Enteritis Caused by Radiation (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
SYN-020 Delayed Release CapsulePhase 1 · Enteritis Caused by RadiationClinicalTrials.gov · fetched Nov 12, 2026

Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020PHASE1 · COMPLETED · started Oct 18, 2021ClinicalTrials.gov NCT05045833 · fetched Nov 12, 2026
Pharmacokinetics, Safety, and Tolerability of SYN-020PHASE1 · COMPLETED · started Mar 22, 2021ClinicalTrials.gov NCT04815993 · fetched Nov 12, 2026
SYN-004 Safety and Tolerability in Allo-HCT SubjectsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 15, 2021ClinicalTrials.gov NCT04692181 · fetched Nov 12, 2026
Efficacy and Safety of SYN-010 in IBS-CPHASE2 · TERMINATED · started Dec 24, 2018ClinicalTrials.gov NCT03763175 · fetched Nov 12, 2026